Insider · CIK 0001005544
NEWHALL CHARLES W III
Reports to the SEC for 34 companies · ROCKVILLE, MD
Transactions
50
Companies
34
Filings
11
CIK
0001005544
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-02-24 | SUPNSUPERNUS PHARMACEUTICALS, INC.A Award | — |
| 2026-02-24 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitD Disposition to Issuer | — |
| 2026-02-18 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitA Award | — |
| 2026-02-18 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award | — |
| 2025-11-21 | SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion | +$195K |
| 2025-11-21 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2025-10-09 | SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale | −$1.21M |
| 2025-10-09 | SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale | −$61.9K |
| 2025-08-27 | SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale | −$161K |
| 2025-08-25 | SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale | −$45K |
| 2025-08-22 | SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale | −$63.5K |
| 2025-02-22 | SUPNSUPERNUS PHARMACEUTICALS, INC.A Award | — |
| 2025-02-22 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer | — |
| 2025-02-19 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award | — |
| 2025-02-19 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitA Award | — |
| 2024-11-11 | SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion | +$183K |
| 2024-11-11 | SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale | −$388K |
| 2024-11-11 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-02-23 | SUPNSUPERNUS PHARMACEUTICALS, INC.A Award | — |
| 2024-02-23 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitD Disposition to Issuer | — |
| 2024-02-22 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award | — |
| 2024-02-22 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award | — |
| 2023-11-16 | SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion | +$68.9K |
| 2023-11-16 | SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale | −$70K |
| 2023-11-16 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2023-02-23 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award | — |
| 2023-02-23 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award | — |
| 2023-02-22 | SUPNSUPERNUS PHARMACEUTICALS, INC.A Award | — |
| 2023-02-22 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer | — |
| 2022-12-28 | SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion | +$68.9K |
| 2022-12-28 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2022-02-22 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award | — |
| 2022-02-22 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award | — |
| 2022-02-19 | SUPNSUPERNUS PHARMACEUTICALS, INC.A Award | — |
| 2022-02-19 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer | — |
| 2021-02-19 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award | — |
| 2021-02-19 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award | — |
| 2020-02-21 | SUPNSUPERNUS PHARMACEUTICALS, INC.A Award | +$125K |
| 2020-02-21 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award | — |
| 2019-02-22 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award | — |
| 2018-04-17 | SUPNSUPERNUS PHARMACEUTICALS, INC.G Gift | — |
| 2018-02-23 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award | — |
| 2017-06-13 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award | — |
| 2017-02-24 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award | — |
| 2016-03-01 | SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award | — |
| 2015-12-03 | SUPNSUPERNUS PHARMACEUTICALS, INC.J Other | — |
| 2015-11-11 | SUPNSUPERNUS PHARMACEUTICALS, INC.J Other | — |
| 2015-07-01 | Vitae Pharmaceuticals, IncJ Other | — |
| 2015-07-01 | Vitae Pharmaceuticals, IncJ Other | — |
| 2015-06-15 | SUPNSUPERNUS PHARMACEUTICALS, INC.J Other | — |
Recent filings
- 4NEWHALL CHARLES W III0001005544-26-000004SEC(opens sec.gov)
- 4NEWHALL CHARLES W III0001005544-26-000002SEC(opens sec.gov)
- 4NEWHALL CHARLES W III0001628280-25-053877SEC(opens sec.gov)
- 4NEWHALL CHARLES W III0001628280-25-044797SEC(opens sec.gov)
- 4NEWHALL CHARLES W III0001005544-25-000008SEC(opens sec.gov)
- 4NEWHALL CHARLES W III0001005544-25-000006SEC(opens sec.gov)
- 4NEWHALL CHARLES W III0001005544-25-000004SEC(opens sec.gov)
- 4NEWHALL CHARLES W III0001628280-25-007476SEC(opens sec.gov)
- 4NEWHALL CHARLES W III0001628280-25-007189SEC(opens sec.gov)
- 4NEWHALL CHARLES W III0001628280-24-047155SEC(opens sec.gov)
- 4NEWHALL CHARLES W III0001104659-24-028281SEC(opens sec.gov)
Companies
- AMICUS THERAPEUTICS, INC.10% Owner
- APPLIED IMAGING CORP10% Owner
- ARYx Therapeutics, Inc.10% Owner
- AUDIENCE INC10% Owner
- BOINGO WIRELESS, INC.10% Owner
- Data Domain, Inc.10% Owner
- DZS INC.10% Owner
- Echo Global Logistics, Inc.10% Owner
- Financial Engines, LLC10% Owner
- FOXHOLLOW TECHNOLOGIES, INC.10% Owner
- FUSION-IO, INC.10% Owner
- GLU MOBILE INC10% Owner
- Groupon, Inc.10% OwnerGRPN
- GYRE THERAPEUTICS, INC.10% OwnerGYRE
- HYPERION THERAPEUTICS INC10% Owner
- INHIBITEX, INC.10% Owner
- INNERWORKINGS INC10% Owner
- Inteliquent, Inc.10% Owner
- INTERCELL USA, INC.10% Owner
- MOTRICITY INC10% Owner
- MYOGEN INC10% Owner
- NETSOLVE INC10% Owner
- OCCAM NETWORKS INC/DE10% Owner
- Paratek Pharmaceuticals, Inc.10% Owner
- PEPLIN INC10% Owner
- PHARMION CORPFormer 10% Owner
- PHARMOS CORPDirector, 10% Owner
- SOURCEFIRE INC10% Owner
- SUPERNUS PHARMACEUTICALS, INC.DirectorSUPN
- Viracta Therapeutics, Inc.10% OwnerVIRX
- Vitae Pharmaceuticals, IncDirector
- VONAGE HOLDINGS CORP10% Owner
- Workday, Inc.10% OwnerWDAY
- ZTI MERGER SUBSIDIARY III INC10% Owner
Address
C/O SUPERNUS PHARMACEUTICALS, INC., 9715 KEY WEST AVENUE
ROCKVILLE, MD, 20850